相关实验视频

Updated: Jul 16, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

高度质瘤复发在西班牙裔患者中延迟,尽管存在严重的社会脆弱性:一项回顾性队列研究

Joshua A Reynolds1, Isabella L Pecorari1, Alexander Ledet1

  • 1Department of Neurological Surgery, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10461, USA.

Cancers
|April 27, 2024
PubMed
概括

西班牙裔种族与更好的高度质瘤 (HGG) 存活率有关,即使在社会脆弱的人群中也是如此. 这项研究发现,西班牙裔患者的瘤复发时间更长,这表明生物因素可能会影响HGG进展.

关键词:
民族身份 民族身份质母细胞瘤是什么高度质瘤高度质瘤社会脆弱性,社会脆弱性时间到复发的时间.

更多相关视频

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.5K
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations04:46

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

1.5K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...